Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fins on sedar

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jun 29, 2022 9:17pm

158 Views

Post# 34792500

RE:Fins on sedar

Lol.....

ITEM 1.11 SUBSEQUENT EVENTS

None.

quote=lscfa]Worst MD&A of any venture co.

Qtr ending	Revenue	Cash flow ops	Working capital
Apr 22	0	(732,899)	1,259,833
Jan 22	0	(758,433)	(31,864)
Oct 21	29,900	(401,852)	518,496
Jul 21	29,040	(474,169)	105,677
Apr 21	190,923	(431,112)	501,131
Jan 21	18,159	(652,653)	566,415